1. 1. Corporate Presentation March 2015
2. 2. Narvitas Medical Devices Develop, patent, manufacture and sell propriety medical devices 3 Initial Platforms, each leveraging the core technology Class 1 - Large market segment High Volume procedures Laparoscopic Epidural Anesthesia Med Surg 8.1 mil procedures worldwide 130 mil birth 60% epidurals In dwelling catheter collection EpiDome Jaws
3. 3. Management Team Glenn Foley Co-Founder & Director Chief Executive Officer AVE, Medtronic, Precision Vascular Arthur Malvett Co-Founder & Director Chief Operating Officer Life Care Medical, Midland Bank Daragh Sharkey Co-Founder & Director Sales & Business Development Aerogen, Altana, Trojan Med
4. 4. Clinical Challenge New Modality Improved Standard of Care Challenge: GYN Laparoscopic Surgery Access Veress Needle is a blind shot Labor intensive 10-12 minutes to full insulflation Published complication rates = 2-4% Vital organs in abdominal bed Revert to open surgery One week hospitalization New Modality
5. 5. Product Development RFQs out to the following engineering design firms: Movement ( Dublin ) LapDome Mini Advant ( Galway ) LapDome Plus Knowvention ( US ) EpiDome Devicix ( US ) Jaws Design LapDome Pedi Narvitas access to engineering firms Narvitas access to University of Minnesota Medical Center MDs
6. 6. Intellectual Property Update Original claims in temporary pneumoperitoneum ( Foley 1 ) Owned by Medical Device International and assigned to Life Care Medical Life Care defaulted Default judgment in favor of Medical Device International in Hong Kong Sealed judgment awarded to Medical Device International Medical Device International assigned property to Narvitas Second set of claims around temporary pneumoperitoneum ( Foley 2 ) Filed in UK Search report uneventful Move to PCT EpiDome claims UK search report yielded inventive steps Move to PCT
7. 7. New Strategic Partners Velocimed St. Jude Veryan BioSensors ( distribution ) Bridgepoint BSC Lutomix Bard MedNova Abbott High Growth Technology Group Narvitas UK branch office
8. 8. Product Pipeline and Timing Device Class CE FDA JMOH I CQ2 2015 CQ4 2015 CQI 2016 2A Kits inc Veress CQ1 2016 CQ2 2016 CQ4 2016 CQ4 2015 CQ4 2015 CQ1 2016 CQ1 2016 CQ2 2016 CQ2 2016
9. 9. Distributor Strategy - USA Surgical Principals Inc. Active Medical EA Medical Mediflex CS Surgical Adler Instruments Support Programs from Eisner Medical Ltd Europe/ME referral centers White papers Registry Published papers Economic Impact analysis Eisner Medical Ltd Consultants who are advising on market entry
10. 10. Financial Forecast
11. 11. Liquidity and Exit
12. 12. What we are looking for? 452k Subscribed 550k Open 2.3m Valuation